Snoring Statistics: The Numbers, and Where Each One Comes From

Almost every snoring statistic you will find online is uncited, and a large share of them are wrong — repeated between articles until the number acquires authority it never earned.

This page carries only figures traceable to a published study, with the study linked. Where the evidence is thin, that is stated instead of smoothed over. If you are quoting a number from here, quote the study rather than this page.

One caution that applies to everything below: snoring is self-reported, and self-report is unreliable. People who sleep alone often do not know they snore. People who share a bed are told. That alone biases most prevalence surveys, and it is the reason the ranges are as wide as they are.

How many people snore

Roughly 40% of men and 24% of women snore habitually. These come from the Wisconsin Sleep Cohort's baseline survey, published in the New England Journal of Medicine in 1993 (Young et al.), covering employed adults aged 30 to 60.

The word doing the work is habitually. Occasional snoring — with a cold, after drinking, on your back — is close to universal, which is why "does everyone snore?" gets a different answer depending on how the question is asked. The honest answer.

How many people have sleep apnea

This is where the numbers diverge most, because the diagnostic threshold moved and the population got heavier.

The 1993 figures: 24% of men and 9% of women aged 30–60 had an apnea-hypopnea index of 5 or more. Adding a daytime-sleepiness requirement — the definition of the clinical syndrome — dropped it to 4% of men and 2% of women (Young et al.).

The 2013 update, twenty years on, in the same cohort: moderate-to-severe sleep-disordered breathing (AHI ≥ 15) in 13% of men and 6% of women aged 30–70 (Peppard et al., American Journal of Epidemiology). The paper attributes most of the rise to increasing obesity.

Globally, a 2019 analysis estimated 936 million adults aged 30–69 with mild-to-severe obstructive sleep apnea, and 425 million with moderate-to-severe (Benjafield et al., Lancet Respiratory Medicine). This is a modelled estimate built from prevalence studies in a limited number of countries, so treat it as an order of magnitude rather than a count.

The undiagnosed share is the statistic that matters most, and it is the least precisely known. Estimates that most moderate-to-severe cases are undiagnosed are widely cited and directionally well supported, but no single study establishes a clean figure. If you snore heavily and have daytime symptoms, the useful conclusion is that not having a diagnosis is weak evidence of not having the condition. The difference between snoring and apnea · Screening questions.

The sex gap, and why it narrows

Men snore more and have apnea more, roughly 2:1 to 3:1 in most surveys. The gap narrows sharply after menopause — a pattern consistent across studies and generally attributed to loss of the progesterone-driven respiratory drive and to changes in fat distribution. Menopause and snoring.

The gap is also partly artefactual. Women present with fatigue, insomnia and mood symptoms more often than with witnessed apneas, which is a poorer match for the screening questionnaires, so some of the difference is under-detection rather than under-occurrence.

Health outcomes

Hypertension. A four-year prospective follow-up in the Wisconsin cohort found a dose-response relationship between sleep-disordered breathing at baseline and new hypertension, with an odds ratio of about 2.9 at AHI ≥ 15 versus none, after adjustment (Peppard et al., NEJM 2000). What this means in practice.

Cardiovascular events. An observational study following men for around ten years found untreated severe apnea associated with substantially higher rates of fatal and non-fatal cardiovascular events than in healthy controls, with treated patients closer to baseline (Marin et al., Lancet 2005). Observational, so treatment self-selection is a live confounder.

Mortality. Eighteen-year follow-up of the Wisconsin cohort found an adjusted hazard ratio of about 3 for all-cause mortality in severe sleep-disordered breathing versus none (Young et al., Sleep 2008).

Snoring without apnea. Much weaker evidence. One study found carotid atherosclerosis far more often in heavy snorers than mild snorers independent of oxygen desaturation (Lee et al., Sleep 2008). Single study, wide confidence interval — a signal, not a settled fact. The full picture.

Treatment

CPAP versus oral appliance. In a randomised crossover trial, CPAP reduced AHI substantially more than a mandibular advancement device, but compliance was better with the appliance, and blood pressure, sleepiness and quality-of-life outcomes came out similar between the two (Phillips et al., AJRCCM 2013). This is the single most useful trial for anyone weighing the choice. The comparison in full.

Weight loss drugs. Two 52-week randomised trials of tirzepatide in adults with moderate-to-severe apnea and obesity reported large AHI reductions against placebo (NEJM 2024). The first drug therapy with trial evidence in this condition. What the trials actually showed.

Numbers you will see that we have left out

• "Snoring affects 90 million Americans." Widely repeated, no traceable primary source. The prevalence percentages above are the defensible version.
• Sleep-loss cost-to-the-economy figures. These come from economic modelling with very wide assumptions, not measurement.
• Anything about how many relationships snoring ends. Survey data from companies selling sleep products. Not evidence.
• Precise decibel claims ("snoring can reach 90 dB"). Loud snoring is genuinely loud, but published measurements vary by microphone placement enough that a single headline number is meaningless.

The absence of a good statistic is not evidence that something is not a problem. Partner sleep disruption is real and well documented in kind, even where the tidy percentage does not exist. What it does to the person next to you.

No consumer product treats sleep apnea

Nothing on this page should be read as suggesting otherwise. Tape, strips, pillows and positional trainers can reduce snoring. None of them treats obstructive sleep apnea, and using one to quieten a symptom you have not had assessed is the one genuinely risky move in this area.

Witnessed breathing pauses, gasping awake, morning headaches, unrefreshing sleep or hard-to-control blood pressure all warrant assessment rather than a product. Is it worth seeing a doctor.